|本期目录/Table of Contents|

[1]刘颂平综述,华克勤审校.巨噬细胞在子宫内膜异位症发生发展中的作用研究现状[J].天津医科大学学报,2018,24(03):271-274.
点击复制

巨噬细胞在子宫内膜异位症发生发展中的作用研究现状(PDF)
分享到:

《天津医科大学学报》[ISSN:1006-8147/CN:12-1259/R]

卷:
24卷
期数:
2018年03期
页码:
271-274
栏目:
综述
出版日期:
2018-05-20

文章信息/Info

Title:
-
作者:
刘颂平12综述华克勤2审校
1.江苏大学附属第四医院妇科, 镇江 212001;2.复旦大学附属妇产科医院妇科,上海 200090
Author(s):
-
关键词:
子宫内膜异位症巨噬细胞病因学免疫靶向治疗
Keywords:
-
分类号:
R711.71
DOI:
-
文献标志码:
A
摘要:
子宫内膜异位症发病机制迄今不明,免疫学病因日益受到重视。巨噬细胞是天然免疫的主要功能细胞,可以通过形成腹腔局部炎症微环境和相对耐受的免疫微环境,促进异位内膜血管新生,发生M2型极化等参与子宫内膜异位症的发生发展。其功能受到雌激素、其他激素及细胞因子的调节,具体调控机制尚不明确。有关靶向治疗包括直接阻断巨噬细胞作用,阻断巨噬细胞M2型极化及雌激素受体抑制剂等,相关研究处于起步阶段,亟待深入探讨。
Abstract:
-

参考文献/References:

[1] Miller J E, Ahn S H, Monsanto S P, et al. Implications of immune dysfunction on endometriosis associated infertility[J].Oncotarget,2017,8(4):7138
[2] 刘颂平,温坚.子宫内膜异位症发病机制研究新进展[J]. 医学综述,2013,19(2):291
[3] Vercellini P, Buggio L, Berlanda N, et al. Estrogen-progestins and progestins for the management of endometriosis[J]. Fertil Steril,2016, 106(7):1552
[4] Chavarro J E, Rich-Edwards J W, Gaskins A J, et al. Contributions of the nurses’ health studies to reproductive nurses’ health studies to reproductive health research[J]. Am J Public Health,2016,106(9):1669
[5] Mahdian S,Aflatoonian R,Yazdi R S,et al. Macrophage migration inhibitory factor as a potential biomarker of endometriosis[J]. Fertil Steril,2015,103(10):153
[6] Takebayashi A,Kimura F,Kishi Y,et al. Subpopulations of macrop-hages within eutopic endometrium of endometriosis patients[J]. Am J Reprod Immunol,2015,73(3):221
[7] Li Y, Adur M K, Kannan A, et al. Progesterone alleviates endometriosis via inhibition of uterine cell proliferation, inflammation and angiogenesis in an immunocompetent mouse model[J]. PLoS One, 2016,11(10):e0165347
[8] Haneya F,Muscalo J J,Weinberg J R. Peritoneal fluid cell populations in infertility patients[J]. Fertil Steril,1981,35(6):696
[9] Na Y J, Lee D H, Kim S C, et al. Effects of peritoneal fluid from endometriosis patients on the release of monocyte-specific chemokines by leukocytes[J]. Arch Gynecol Obstet, 2011,283(6):1333
[10] Akoum A, Kong J, Metz C, et a1.Spontaneous and stimulated secIelion of monocyte chemotactic protein-l and maerophage migration inhibitory factor by peritoneal macmphages in women with and without endometriosis[J]. Fertil Steril,2002,77(5):989
[11] Devreotes P,Horwitz A R. Signaling networks that regulate cell migration[J]. Golg Spring Harb Perspeet Biol,2015,7(8):a005959
[12] DiCosmo-Ponticello C J,Hoover D,Coffman F D,et a1.MIF inhibits monocytic movement through a non-canonical receptor and disruption of temporal Rho GTPase activities in U-937 cells[J]. Cytokine,2014,69(1):47
[13] 李建,胡玉红,张燕. MIF降低子宫内膜异位症患者腹腔液巨噬细胞的运动速度[J]. 山西医科大学学报,2016,47(4):373
[14] Beste M T,Pfaffle—Doyle N,Prentice E A,et a1. Molecular network analysis of endometriosis reveals a role for c-Jun-regulated macrophage activation[J]. Sci Transl Med,2014,6(222):222ral6
[15] Greaves E,Cousins F L, Murray A,et al. A novel mouse model of endometriosis mimics human phenotype and reveals insights into the inflammatory contribution of shed endometrium[J]. Am J Pathol,2014,184(7):1930
[16] Wu M H,Chuang P C,Lin Y J,et a1. Suppression of annexin A2 by prostaglandin E2 impairs phagocytic ability of peritoneal macrophages in women with endometriosis[J]. Hum Reprod,2013, 28(4):1045
[17] Kang Y J,Jeung I C,Park A,et a1. An increased level of IL-6 suppresses NK cell activity in peritoneal fluid of patients with endometriosis via regulation of SHP-2expression[J]. Hum Reprod,2014,29(10):2176
[18] Vercellini P,Viganb P,Somigliana E,et a1. Endometriosis:pathogenesis and treatment[J]. Nat Rev Endecrinol,2014,10(5):261
[19] Yadav L,Puri N,Rastogi V,et al. Tumour angiogenesis and angiogenic inhibitors: A review [J]. J Clin Diagn Res,2015,9(6):XE01
[20] Capobianco A, Rovere-Querini P. Endometriosis, a disease of the macrophage[J]. Front Immunol,2013,4(4):9
[21] Na Y J,Yang S H,Baek D W,et al. Effects of peritoneal fluid from endometriosis patients on the release of vascular endothelial growth factor by neutrophils and monocytes [J]. Hum Reprod,2006,21(7):1846
[22] McLaren J,Prentice A,Charnock-Jones D S,et a1.Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids[J]. J Clin Invest,1996,98(2):482
[23] Lin Y J,Lai M D,Lei H Y,et a1. Neutrophils and macrophages promote angiogenesis in the early stage of endometriosis in a mouse model[J]. Endocrinology, 2006,147(3):1278
[24] Yang Z,Li L,Chen L,et al. PARP -1 mediates LPS –induced HMGB1 release by macrophages through regulation of HMGB1 acetylation[J]. J Immunol,2014,193(12):6114
[25] Yang S,Xu L,Yang T,et al. High-mobility group box-1 and its role in angiogenesis[J]. J Leukoc Biol,2014,95(4):563
[26] Tao Y,zhang Q,Huang W,et al. The peritoneal leptin,MCP-l and TNF-a in the pathogenesis of endometriosis—associated infenility[J].Am J Repmd Immunol,201l,65(4):403
[27] Wynn T A, Chawla A, Pollard J W. Macrophage biology in development, homeostasis and disease [J]. Nature, 2013, 496(7446): 445
[28] Wang Y,Chen H,Wang N,et a1.Combined 176-estradiol with TCDD promotes M2 polarization of macrophages in the endometriotic milieu with aid of the interaction between endometrial stromal ceils and macmphages[J]. Plos One,2015,10(5):eol25559
[29] Bacci M,Capobianco A,Monno A,et al. Macrophages are alternatively activated in patients with endometriosis and required for growth and vascularization of lesions in a mouse model of disease[J].Am J Pathol,2009,175(2):547
[30] Yuan M, Li D, An M, et al. Rediscovering peritoneal macrophages in a murine endometriosis model[J]. Hum Reprod, 2017,32(1):94
[31] Xu J, Chi F, Tsukamoto H. Notch signaling and M1 macrophage activation in obesity-alcohol synergism [J]. Clin Res Hepatol Gastroen-terol, 2015, 39 (Suppl 1) : S24
[32] Xu F, Kang Y, Zhang H, et al. Akt1-mediated regulation of macrophage polarization in a murine model of Staphylococcus aureus pulmonary infection [J]. J Infect Dis, 2013, 208(3): 528
[33] 胡玉红,宋美玉. 巨噬细胞活性与子宫内膜异位症发生的关系[J]. 贵阳医学院学报,2016,4(14):418
[34] 刘黎,胡静平,岳艳.雌激素通过调节IRF4促进巨噬细胞向M2型极化[J].现代免疫学,2013,33(4):285
[35] Greaves E,Temp J,Esnal-Zufiurre A,et a1.Estradiol is a critical mediator of macrophage-nerve cross talk in peritoneal endometriosis[J]. Am J Pathol,2015,185(8):2286
[36] Zhang X, Zhou M, Guo Y, et al. 1,25-dihydroxyvitamin D(3) promotes high glucose-induced M1 macrophage switching to M2 via the VDR-PPAR gamma signaling pathway[J]. Biomed Res Int, 2015, 2015:157834
[37] Odegaard J I, Ricardo-Gonzalez R R, Goforth M H, et al. Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance [J]. Nature, 2007, 447(7148): 1116
[38] Gordon S,Martinez F O. Alternative activation of macrophages:mechanism andfunctions[J]. Immunity,2010,32(5):593
[39] Heublein S,Vrekoussis T,Kuhn C,et a1. Inducers of G-protein coupled estrogen receptor(GPER)in endometriosis:potential implications for macrophages and follicle maturation[J]. J Reprod Immunol,2013,97(1):95
[40] PLies C H,Cannarile M A,Hoves S,et a1. Targeting tumor-associated macrophages with anti-CSF-IR antibody reveals a strategy for cancertherapy[J]. Cancer Ceil,2014,25(6):846
[41] Zhao Y,Gong P,Chen Y,et a1. Dual suppression of estrogenic and inflammatory activities for targeting of endometriosis[J]. Sci Transl Med,2015,7(271):27lra9

相似文献/References:

[1]樊亚童,郑鉴,肖俊,等.炎症反应中巨噬细胞的Siglec-G分子对DAMPs和PAMPs的识别及调节作用[J].天津医科大学学报,2018,24(02):93.
 FAN Ya-tong,ZHENG Jian,XIAO Jun,et al.Identification of DAMPs and PAMPs by Siglec-G in macrophages and its regulatory effect on DAMPs and PAMPs in inflammatory response[J].Journal of Tianjin Medical University,2018,24(03):93.
[2]刘怡瑾,马平川,朱颖军.腹壁子宫内膜异位症的临床资料分析[J].天津医科大学学报,2018,24(04):336.
 LIU Yi-jin,MA Ping-chuan,ZHU Ying-jun.Clinical analysis of abdominal wall endometriosis[J].Journal of Tianjin Medical University,2018,24(03):336.
[3]吴桃,呼学敏,杨玉芳,等.基于生物信息学分析探讨子宫内膜异位症恶变的机制[J].天津医科大学学报,2023,29(04):366.
 WU Tao,HU Xue-min,YANG Yu-fang,et al.Exploring the mechanism of malignant transformation of endometriosis based on bioinformatics analysis[J].Journal of Tianjin Medical University,2023,29(03):366.

备注/Memo

备注/Memo:
文章编号 1006-8147(2018)03-0271-04
基金项目 江苏省“333”工程科研资助项目(BRA2017146),吴阶平医学基金资助项目(320.6755.15023)
作者简介 刘颂平(1979-),女,副主任医师,硕士,研究方向:子宫内膜异位症;通信作者:华克勤,E-mail:huakeqindoc@163.com。
更新日期/Last Update: 2018-05-20